Rebody Health Review
Rebody Health scores highest on state availability and ease of access.
Rebody Health: No longer sells GLP-1s — Rebody Health now sells peptide and hormone therapies. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →Rebody Health sold compounded and brand-name semaglutide and tirzepatide through its telehealth service. It no longer offers any GLP-1: rebodyhealth.com now sells prescription peptide and hormone therapies, and its old GLP-1 pricing and product pages no longer exist.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rebody Health
bmiMD
Best for: one flat compounded GLP-1 price at every dose, down to $99/mo semaglutide on a 12-month plan
Editorial score · methodology
altRX
Best for: low-cost compounded GLP-1s with brand-name Zepbound, Wegovy and Ozempic as options
Editorial score · methodology
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Rebody Health at a glance
- Type
- GLP-1 telehealth provider
- Availability
- 47 states
- FDA status
- No FDA warning letter on record
How we scored Rebody Health
Each dimension is scored algorithmically from Rebody Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.2/10Rebody Health no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
6.6/10Rebody Health's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence — weigh the clinical support carefully.
User Experience15%
8.0/10Online intake and platform experience; 2 platform features disclosed.
Trust & Safety15%
8.9/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
9.4/10Rebody Health is available in 47 states — all but Massachusetts, Rhode Island, Vermont.
Support10%
7.0/10Rebody Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rebody Health review
Last checked October 2026- Confirmed availability in 47 states
- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What we like
- Review page kept live so former patients get a straight answer
Watch-outs
- No longer sells semaglutide, tirzepatide or any brand-name GLP-1
- Its old GLP-1 pricing and product pages no longer exist
- Remaining catalog is peptide and hormone therapy, not GLP-1 weight-loss care
Is Rebody Health still an option?
Rebody Health no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.
If you were a Rebody Health patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage, starting with the alternatives below.
The Bottom Line
Rebody Health scores highest on state availability and ease of access.
Rebody Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rebody Health review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.